Evaluation of F18-deoxyglucose positron emission tomography (FDG-PET) to assess the nature of neurogenic tumours

European Journal of Surgical Oncology

Volumn 29, Issue 6, 2003, Pages 536-541

  Cardona, S ^a   Schwarzbach, M ^a   Hinz, Ulf ^a   Dimitrakopoulou Strauss, A ^b   Attigah, A ^a   Mechtersheimer, G ^a   Lehnert, Thomas ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

FDG PET; Malignant peripheral sheath tumours; Neurofibroma; Neurofibromatosis 1

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; BENIGN TUMOR; CANCER RECURRENCE; CANCER SURGERY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MALIGNANT NEOPLASTIC DISEASE; MEDICAL ASSESSMENT; NERVE SHEATH TUMOR; NEUROFIBROMATOSIS; NEUROGENIC TUMOR; NON INVASIVE MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; SOFT TISSUE TUMOR; STANDARDIZATION; STATISTICAL SIGNIFICANCE; THREE DIMENSIONAL IMAGING;

EID: 0041976864     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0748-7983(03)00055-6     Document Type: Article

References (20)

1. Ducatman BS, Scheithauer BW, Piepgras DG. Malignant peripheral nerve sheath tumours. A clinicopathological study of 120 cases. Cancer 1986; 57: 2006-21.
2. Korf BR. Plexiform neurofibromas. Am J Med Gen 1999; 89: 31-7.
3. Hughes TMD, Spillane AJ. Imaging of soft tissue tumours. Br J Surg 2000; 87: 259-60.
4. Fortman BJ, Kuszyk BS, Urban BA, Fishman EK. Neurofibromatosis type I: a diagnostic mimicker at CT. Radiographics 2001; 21: 601-12.
5. Crim JR, Seeger LL, Yao L, Chandnani V, Eckardt JJ. Diagnosis of soft-tissue masses with MR imaging: can benign masses be differentiated from malignant ones? Radiology 1992; 185: 581-6.
6. Ramanathan RC, Meirion TJ. Malignant peripheral nerve sheath tumours associated with Von Recklinghausen's neurofibromatosis. Eur J Surg Oncol 1999; 25: 190-3.
7. Coffin CM, Dehner LP. Cellular peripheral neural tumours (neurofibromas) in children and adolescents: a clinicopathological and immunohistochemical study. Pediatr Pathol 1990; 10: 351-61.
8. Warburg O. The metabolism of tumours. New York: Smith, 1931.
9. Schwarzbach M, Dimitrakopoulou-Strauss A, Willeke F, Hinz U, Strauss L, Zhang Y, Mechtersheimer G, Attigah N, Lehnert T, Herfarth C. Clinical value of [18-F] fluorodeoxyglucose positron emission tomography imaging in soft tissue sarcomas. Ann Surg 2000; 231: 380-6.
10. Schwarzbach MH, Dimitrakopoulou-Strauss A, Mechtersheimer G, Hinz U, Willeke F, Cardona S, Attigah N, Strauss LG, Herfarth C, Lehnert T. Assessment of soft tissue lesions suspicious for liposarcoma by F18-deoxyglucose (FDG) positron emission tomography (PET). Anticancer Res 2001; 21: 3609-14.
11. National Institutes of Health Consensus Development Conference. Neurofibromatosis: conference statement. Arch Neurol 1987; 45: 575-8.
12. Trojani M, Contesso G, Coindre JM, Rouesse J, Bui NB, de Mascarel A, Goussot JF, David M, Bonichon F, Lagarde C. Soft tissue sarcomas of adults. Study of pathological prognostic variables and definition of a histological grading system. Int J Cancer 1984; 33: 37-42.
13. 18F-FGD studies in patients with primary and recurrent soft-tissue sarcomas: impact on diagnosis and correlation. J Nucl Med 200 1; 42: 713-20.
14. Newcombe RG. Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med 1998; 7: 857-72.
15. Rasmussen SA, Friedman JM. NFI gene and neurofibromatosis I. Am J Epidemiol 2000; 151: 33-40.
16. Woodruff JM. Pathology of tumours of the peripheral nerve sheath in type 1 neurofibromatosis. Am J Med Gen 1999; 89: 23-30.
17. Nielsen GP, Stemmer-Rachaminov A, Ino Y, Müller MB, Rosenberg AE, Louis DN. Malignant transformation of neurofibromas in neurofibromatosis I is associated with CDKN2A/p16 inactivation. Am J Pathol 1999; 155: 1879-84.
18. Lyn BT-Y, Weiss LM, Medeiros LJ. Neurofibroma and cellular neurofibroma with atypia. Am J Surg Pathol 1997; 21: 1443-9.
19. Solomon SB, Semih DA, Nicol TL, Campbell JN, Pomper MG. Positron emission tomography and the detection and management of sarcomatous transformation in neurofibromas. Clin Nucl Med 2001; 26: 525-8.
20. 18FDG-PET) in the detection of malignant peripheral nerve sheath tumours arising from within plexiform neurofibromas in neurofibromatosis I. J Neurol Neurosurg Psychiatry 2000; 68: 353-7.